Morphologic and molecular prognostic markers in prostate cancer

被引：29
|
作者：
Ross, JS [1 ]
Sheehan, CE
Dolen, EM
Kallakury, BVS
机构：
[1] Albany Med Coll, Dept Pathol & Lab Med, Albany, NY 12208 USA
[2] Albany Med Coll, Dept Radiol, Albany, NY 12208 USA
[3] Millennium Pharmaceut Inc, Cambridge, MA USA
[4] Georgetown Univ, Sch Med, Dept Pathol, Georgetown, MD USA
来源：
ADVANCES IN ANATOMIC PATHOLOGY | 2002年 / 9卷 / 02期
关键词：
prostate cancer; biomarker; prognosis; grade; stage; DNA ploidy; cell proliferation; oncogene; cell adhesion; HER-2/neu; apoptosis; proteasome;
D O I：
10.1097/00125480-200203000-00003
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
In this review, a series of traditional morphology-based measurements, relatively well-documented ancillary biomarkers, and emerging molecular assays are evaluated for their relative ability to predict prognosis in prostate cancer. Prognostic factors that have achieved widespread use and are classified as category I by the College of American Pathologists' Solid Tumor Prognostic Factor Consensus Conference are compared with newer tests that are beginning to be used in clinical practice (category II) and emerging molecular-based assays that have yet to be widely validated in the published literature or in clinical trials (category III).
引用
收藏
页码：115 / 128
页数：14
相关论文
共 50 条
  • [41] Molecular prognostic and predictive markers of breast cancer treatment
    de Cremoux, P.
    BULLETIN DU CANCER, 2010, 97 (11) : 1297 - 1304
  • [42] Prognostic value study of lung cancer molecular markers
    Garcia Lujan, Ricardo
    Conde Gallego, Esther
    Lopez Rios, Fernando
    Luis Martin De Nicolas, Jose
    Sanchez Cespedes, Montserrat
    Garcia Quero, Cristina
    Lopez Encuentra, Angel
    MEDICINA CLINICA, 2009, 132 (14): : 529 - 536
  • [43] Large scale genomic instability as an additive prognostic marker in early prostate cancer
    Pretorius, Maria E.
    Waehre, Hakon
    Abeler, Vera M.
    Davidson, Ben
    Vlatkovic, Ljiljana
    Lothe, Ragnhild A.
    Giercksky, Karl-Erik
    Danielsen, Havard E.
    CELLULAR ONCOLOGY, 2009, 31 (04) : 251 - 259
  • [44] Prognostic and Predictive Molecular Markers in Cholangiocarcinoma
    Pavicevic, Sandra
    Reichelt, Sophie
    Uluk, Deniz
    Lurje, Isabella
    Engelmann, Cornelius
    Modest, Dominik P.
    Pelzer, Uwe
    Krenzien, Felix
    Raschzok, Nathanael
    Benzing, Christian
    Sauer, Igor M.
    Stintzing, Sebastian
    Tacke, Frank
    Schoening, Wenzel
    Schmelzle, Moritz
    Pratschke, Johann
    Lurje, Georg
    CANCERS, 2022, 14 (04)
  • [45] Prognostic relevance of molecular markers of oral cancer - A review
    Schliephake, H
    INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2003, 32 (03) : 233 - 245
  • [46] MOLECULAR AND CELLULAR MARKERS FOR METASTATIC PROSTATE-CANCER
    RINKERSCHAEFFER, CW
    ISAACS, WB
    ISAACS, JT
    CANCER AND METASTASIS REVIEWS, 1993, 12 (01) : 3 - 10
  • [47] Prognostic importance of selected molecular immunohistochemical markers and DNA ploidy in endometrial cancer
    Kudela, M.
    Pilka, R.
    Lubusky, M.
    Hejtmanek, P.
    Dzubak, P.
    Brychtova, S.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2012, 33 (02) : 159 - 163
  • [48] LINC00657 exhibits oncogenic properties in prostate cancer and may serve as a prognostic biomarker in cancer
    Wen, Yaoan
    Zhan, Shuyuan
    Wang, Shenfan
    Yang, Longjie
    Yang, Siqi
    Zheng, Song
    BMC CANCER, 2025, 25 (01)
  • [49] Molecular markers for predicting prostate cancer stage and survival
    Dunsmuir, WD
    Gillett, CE
    Meyer, LC
    Young, MP
    Corbishley, C
    Eeles, RA
    Kirby, RS
    BJU INTERNATIONAL, 2000, 86 (07) : 869 - 878
  • [50] Methylation markers for prostate cancer prognosis: a systematic review
    Chao, Chun
    Chi, Margaret
    Preciado, Melissa
    Black, Mary Helen
    CANCER CAUSES & CONTROL, 2013, 24 (09) : 1615 - 1641
12345